🍎 🍕 Less apples, more pizza 🤔 Have you seen Buffett’s portfolio recently?Explore for Free

US urges court to preserve Obamacare mandate to cover cancer screenings, HIV drugs

Published 03/04/2024, 06:10 AM
Updated 03/04/2024, 04:51 PM
© Reuters. A sign on an insurance store advertises Obamacare in San Ysidro, San Diego, California, U.S., October 26, 2017. REUTERS/Mike Blake/File Photo
GILD
-
PFE
-

By Brendan Pierson

(Reuters) -President Joe Biden's administration on Monday urged a U.S. appeals court to preserve a federal mandate that requires health insurers to cover preventive care services including HIV-preventing medication and cancer screenings at no extra cost to patients.

"These are preventive services provisions that are critical and life-saving to millions of Americans," Daniel Aguilar, a lawyer for the government, told a three-judge panel of the New Orleans-based 5th U.S. Circuit Court of Appeals during arguments in the administration's appeal.

The administration is asking the 5th Circuit to overturn a federal judge's ruling that, if allowed to take full effect, would strike down the mandate that insurers cover a wide range of services chosen by a federal task force without co-pays. The mandate is part of the 2010 Affordable Care Act (ACA), often called Obamacare because it was championed by then-President Barack Obama.

The judges during the arguments did not clearly signal how they would rule.

The PrEP drugs approved in the United States to prevent HIV infection, which can cause AIDS, are made by Gilead Sciences (NASDAQ:GILD) and by ViiV Healthcare, a joint venture of GSK, Pfizer (NYSE:PFE) and Shionogi.

A group of businesses led by Texas-based Christian wellness center operator Braidwood Management in 2020 sued over the mandate. While they brought their case because they objected on religious grounds to covering HIV pre-exposure prophylaxis (PrEP), they argued that the entire mandate violated the U.S. Constitution because it gave too much power to a task force chosen by a mid-level U.S. health official, rather than appointed by the president and confirmed by the Senate.

U.S. District Judge Reed O'Connor in Fort Worth in March 2023 agreed and blocked enforcement of the preventive care mandate nationwide.

Jonathan Mitchell, a lawyer for Braidwood, argued that the 5th Circuit should uphold that conclusion.

"The individuals who wield these powers to impose compulsory preventive care coverage mandates on private insurers hold sufficient authority to make them into officers of the United States," Mitchell said.

The Biden administration has argued that U.S. Secretary of Health and Human Services Xavier Becerra, who was confirmed by the Senate, can retroactively "ratify" the task force's decisions. Becerra issued a memo in 2022 doing so, but Mitchell argued that the Obamacare law did not allow it.

Aguilar also told the judges on Monday that even if the court agrees with O'Connor's conclusions, it should narrow his order to give the plaintiffs what they wanted while preserving as much of Obamacare as possible - an approach he likened to using a "scalpel" instead of a "sledgehammer."

"Plaintiffs don't have a particular reason to object to somebody in Wisconsin receiving lung cancer screening without cost sharing," Aguilar said.

© Reuters. A sign on an insurance store advertises Obamacare in San Ysidro, San Diego, California, U.S., October 26, 2017. REUTERS/Mike Blake/File Photo

O'Connor's ruling does not apply to services the task force recommended before the ACA was enacted, including breast cancer screening.

Two members of the 5th Circuit panel, Circuit Judges Don Willett and Cory Wilson, were appointed by Republican former President Donald Trump, and the third, Circuit Judge Irma Carrillo Ramirez, was appointed by Biden, a Democrat.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.